Q4 2024 Management View CEO David Loew emphasized Ipsen’s sustained growth in 2024, with total sales increasing by 9.9%. He highlighted the strong performance of the ex-Somatuline portfolio, which ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results